NIO Shares Surge 93 After ES9 Launch Market Eyes Monthly Delivery Data Monte Rosa Therapeutics GLUE Q1 2026 Earnings EPS Miss Highlights Ongoing ClinicalStage Costs Stock Gains Modestly Canons Continuous Transformation Drives Next Growth Phase